Editas Medicine, Inc.
EDIT
$2.22
-$0.13-5.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 35.84M | 32.31M | 61.76M | 67.03M | 69.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.84M | 32.31M | 61.76M | 67.03M | 69.41M |
| Cost of Revenue | 99.28M | 101.28M | 122.23M | 115.10M | 115.50M |
| Gross Profit | -63.45M | -68.97M | -60.47M | -48.07M | -46.09M |
| SG&A Expenses | 66.02M | 71.99M | 70.09M | 66.99M | 65.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 243.08M | 271.23M | 290.28M | 280.05M | 254.62M |
| Operating Income | -207.24M | -238.92M | -228.52M | -213.02M | -185.21M |
| Income Before Tax | -251.23M | -237.09M | -210.57M | -193.45M | -166.13M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -251.23 | -237.09 | -210.57 | -193.45 | -166.13 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -251.23M | -237.09M | -210.57M | -193.45M | -166.13M |
| EBIT | -207.24M | -238.92M | -228.52M | -213.02M | -185.21M |
| EBITDA | -200.92M | -233.11M | -222.63M | -207.21M | -179.28M |
| EPS Basic | -3.04 | -2.88 | -2.56 | -2.36 | -2.10 |
| Normalized Basic EPS | -1.50 | -1.71 | -1.59 | -1.46 | -1.30 |
| EPS Diluted | -3.04 | -2.88 | -2.56 | -2.36 | -2.10 |
| Normalized Diluted EPS | -1.50 | -1.71 | -1.59 | -1.46 | -1.30 |
| Average Basic Shares Outstanding | 330.46M | 329.35M | 328.44M | 327.61M | 316.67M |
| Average Diluted Shares Outstanding | 330.46M | 329.35M | 328.44M | 327.61M | 316.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |